Frequency and prognostic implications of conduction defects in acute myocardial infarction since the introduction of thrombolytic therapy
R A Archbold1, J W Sayer, S Ray
1Department of Cardiology, Newham General Hospital, London, U.K.
Insights
Conduction defects complicate acute myocardial infarction (AMI), increasing cardiac mortality. Advanced conduction defects, such as bundle branch block, indicate a worse prognosis, though thrombolytic therapy may reduce severe defect rates.
Area of Science:
- Cardiology
- Electrophysiology
- Acute Myocardial Infarction
Background:
- Conduction defects are linked to poor prognosis in acute myocardial infarction (AMI).
- Limited data exist on conduction defect incidence and outcomes post-thrombolytic therapy introduction.
Purpose of the Study:
- To determine the frequency of conduction defects in AMI patients treated with thrombolysis.
- To assess the prognostic impact of these conduction defects on patient outcomes.
Main Methods:
- Prospective analysis of 1225 consecutive AMI patients in a coronary care unit (1988-1994).
- Classification of conduction defects: atrioventricular node block, bundle branch block, bifascicular block, and complete heart block.
- Survival analysis to evaluate short- and long-term cardiac mortality.
Main Results:
- Conduction defects occurred in 16% of 1220 analyzed patients.
- Higher degrees of block were associated with diabetes, prior infarction, Q-wave, anterior infarction, and left ventricular failure.
- Conduction defects significantly increased short- and long-term cardiac mortality, with prognosis worsening by defect severity.
Conclusions:
- Conduction defects significantly impact AMI prognosis, with advanced bundle branch block associated with the worst outcomes.
- A slight decrease in severe conduction defects suggests potential benefits of thrombolytic therapy in reducing infarct size.
Objective:
To document the frequency of conduction defects and their influence on prognosis in a large series of patients with acute myocardial infarction who underwent coronary care during a period when thrombolytic therapy was in common usage.
Background:
Conduction defects have been associated with an adverse prognosis following acute myocardial infarction, but there are few data on the incidence and outcome of conduction defects since the introduction of thrombolytic therapy.
Patients And Methods:
The study group comprised 1225 consecutive patients with acute myocardial infarction treated in the coronary care unit from 1 January 1988 to 31 December 1994. Conduction defects were recorded prospectively and were classified as follows: complete atrioventricular node block associated with narrow complex escape rhythms; left or right bundle branch block; bifascicular block; complete heart block involving both bundle branches.
Results:
Electrocardiographic data were available in 1220 patients. Complete atrioventricular node block occurred in 65 (5.3%), left and right bundle branch block in 29 (2.4%) and 44 (3.6%) bifascicular block in 36 (2.9%) and complete heart block involving both bundle branches in 20 (1.6%). The more advanced degrees of block in the bundle branches occurred more commonly in patients with diabetes, previous infarction. Q-wave infarction, anterior infarction and left ventricular failure. Survival analysis showed an increased short- and long-term cardiac mortality in patients with conduction defects, prognosis worsening as the severity of the conduction defect increased.
Conclusion:
Conduction defects complicated acute myocardial infarction in 16% of cases and had a graded impact on the short- and long-term prognosis, patients with advanced bundle branch involvement faring worst. The data showed a small decline in the rate of severe conduction defects compared with previous studies, possibly reflecting the beneficial effects of thrombolytic therapy on infarct size.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:21Myocarditis I: Introduction
01:30Acute Coronary Syndrome I: Introduction
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:28Acute Coronary Syndrome IV: Interprofessional Care